Gene · 839
Papers3,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma. | Front Cell Dev Biol | 2022 | 36204682 | PubTator, text mining | PubMed |
| CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer. | Int J Anal Chem | 2022 | 36199443 | PubTator, text mining | PubMed |
| Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington's disease. | Regen Ther | 2022 | 36196447 | PubTator, text mining | PubMed |
| Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma. | Gastroenterol Rep (Oxf) | 2022 | 36196256 | PubTator, text mining | PubMed |
| P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration. | Adv Cancer Biol Metastasis | 2022 | 36187341 | PubTator, text mining | PubMed |
| PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer. | Front Genet | 2022 | 36186438 | PubTator, text mining | PubMed |
| Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer. | J Biol Chem | 2022 | 36183837 | PubTator, text mining | PubMed |
| The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia. | Front Immunol | 2022 | 36177050 | PubTator, text mining | PubMed |
| Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method. | Cell Mol Life Sci | 2022 | 36169732 | PubTator, text mining | PubMed |
| A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma. | BMC Med Genomics | 2022 | 36163033 | PubTator, text mining | PubMed |
| Chaperone-assisted E3 ligase CHIP: A double agent in cancer. | Genes Dis | 2022 | 36157498 | PubTator, text mining | PubMed |
| Pyroptosis patterns of colon cancer could aid to estimate prognosis, microenvironment and immunotherapy: evidence from multi-omics analysis. | Aging (Albany NY) | 2022 | 36152052 | PubTator, text mining | PubMed |
| Role of Caspases and Gasdermin A during HSV-1 Infection in Mice. | Viruses | 2022 | 36146839 | PubTator, text mining | PubMed |
| Does Pyroptosis Play a Role in Inflammasome-Related Disorders? | Int J Mol Sci | 2022 | 36142364 | PubTator, text mining | PubMed |
| microRNAs Control Antiviral Immune Response, Cell Death and Chemotaxis Pathways in Human Neuronal Precursor Cells (NPCs) during Zika Virus Infection. | Int J Mol Sci | 2022 | 36142200 | PubTator, text mining | PubMed |
| ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity. | Int J Mol Sci | 2022 | 36142136 | PubTator, text mining | PubMed |
| Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome. | Cancers (Basel) | 2022 | 36139700 | PubTator, text mining | PubMed |
| Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. | BMC Cancer | 2022 | 36127654 | PubTator, text mining | PubMed |
| Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes. | Medicine (Baltimore) | 2022 | 36123889 | PubTator, text mining | PubMed |
| Identification and verification of the pyroptosis-related prognostic signature and its associated regulatory axis in bladder cancer. | Front Cell Dev Biol | 2022 | 36120583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/papers?page=26